Social model of disability

From WikiMD's WELLNESSPEDIA

Social model of disability is a perspective that views disability as a socially created problem and not an attribute of an individual. It distinguishes between 'impairment' (the physical or mental limitation) and 'disability' (the social exclusion that results from societal barriers). The model emphasizes societal change to accommodate individuals with impairments, rather than expecting those individuals to fit into a society not designed for them.

Origins[edit]

The social model of disability was developed by the Union of the Physically Impaired Against Segregation (UPIAS) in the United Kingdom during the 1970s. It was a response to the traditional medical model of disability, which views disability as an individual problem that needs to be fixed or cured.

Principles[edit]

The social model of disability proposes that societal attitudes, barriers and structures are the primary cause of disability, not the individual's physical or mental differences. It argues that society should be structured and organized in such a way that all individuals, regardless of their physical or mental capabilities, can participate fully in all aspects of life.

Impact[edit]

The social model of disability has had a significant impact on disability rights movements and policies worldwide. It has influenced the development of disability rights legislation, such as the Americans with Disabilities Act (ADA) in the United States and the Equality Act 2010 in the United Kingdom. It has also shaped the United Nations Convention on the Rights of Persons with Disabilities (UNCRPD).

Criticisms[edit]

While the social model of disability has been influential, it has also faced criticism. Some argue that it overlooks the experiences of individuals with impairments, particularly those with chronic pain or illness. Others suggest that it fails to acknowledge the potential benefits of medical interventions.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.